Nexien BioPharma (NXEN) Stock News

Nexien BioPharma (OTCQB:NXEN) has engaged CORE IR, a strategic firm specializing in investor and public relations, to enhance communications with investors. CORE IR aims to amplify market awareness and present Nexien's business model and growth strategies to both institutional and retail investors. CEO Richard Greenberg expressed enthusiasm for this partnership, highlighting its potential to boost outreach and engagement with the investment community. Nexien focuses on developing FDA-compliant cannabinoid pharmaceuticals to address various medical conditions.